Clinical trials: Male Sexual Dysfunction
Erectile Dysfunction
REPEAT - Real-Life Perception of Efficacy, Attitude, Satisfaction and Safety of Levitra Therapy
The aim of this prospective, non-interventional post-marketing surveillance study is to obtain data on safety and efficacy of Levitra in routine treatment of erectile dysfunction.
- Trial name
- NCT00874679
- Testing
- Levitra (Vardenafil, BAY38-9456)
- Where
- 15 sites in China, Croatia and 13 more
- Volunteers
- 7,293 people
- Sponsor
- Bayer
Erectile Dysfunction
Extracorporeal Shock Wave Therapy for the Treatment of Erectile Dysfunction
Low intensity shockwaves have been proven in animal studies to induce local growth of new blood vessels from existing ones. The hypothesis of this study is that shockwave therapy could improve the symptoms of patients with…
- Trial name
- NCT00901056
- Testing
- Extracorporeal Shockwave Therapy
- Where
- Israel
- Volunteers
- 20 people
- Sponsor
- Medispec
Erectile Dysfunction
Safety and Efficacy of YHD1023 in Erectile Dysfunction
The objective of this study is to assess the safety and efficacy of oral YHD1023 5g or 10g on erectile dysfunction to investigate the optimal recommended dosage.
- Trial name
- NCT01423370
- Testing
- YHD1023, Cialis
- Where
- South Korea
- Volunteers
- 104 people
- Sponsor
- Yuhan Corporation
Sexual Dysfunction, Ejaculation
A Study of Withdrawal Effects With Dapoxetine in the Treatment of Premature Ejaculation
The primary purpose of the study is to assess the possible withdrawal effects after abruptly stopping daily therapy with dapoxetine compared with continuing daily therapy in men with premature ejaculation (PE).
- Trial name
- NCT00210613
- Testing
- Dapoxetine
- Volunteers
- 199 people
- Sponsor
- Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Erectile Dysfunction
Placebo-controlled Study Evaluating the Efficacy and Safety of Vardenafil in Subjects With Erectile Dysfunction
This study tested the hypothesis that vardenafil was both clinically effective and well-tolerated compared to placebo in men diagnosed as being unresponsive to sildenafil.
- Trial name
- NCT00656188
- Testing
- Levitra (Vardenafil, BAY38-9456)
- Volunteers
- 463 people
- Sponsor
- Bayer
Erectile Dysfunction
Evaluation of the Safety and Efficacy of Vardenafil in Subjects With Erectile Dysfunction
Erectile dysfunction (ED) is defined as the inability to achieve or maintain an erection sufficient for satisfactory sexual performance.
- Trial name
- NCT00681772
- Testing
- Levitra (Vardenafil, BAY38-9456)
- Volunteers
- 333 people
- Sponsor
- Bayer
Erectile Dysfunction
Pharmacokinetics of Sildenafil Following Administration of an Chewable Tablet of Sildenafil Relative to Viagra® Conventional Oral Tablet in Healthy Volunteers
This is a single dose open-label comparative pharmacokinetic study to assess the pharmacokinetic characteristics of sildenafil between HIP0908 (chewable tablet) and Viagra (tablet) in healthy male subjects.
- Trial name
- NCT01514903
- Testing
- HIP0908, viagra
- Where
- South Korea
- Volunteers
- 54 people, healthy volunteers welcome
- Sponsor
- Hanmi Pharmaceutical Company Limited
Erectile Dysfunction
Vardenafil Orodispersible Tablet (ODT) Versus Placebo in Males With Erectile Dysfunction, 50% of Whom Are to be 65 Years or Older.
This study investigates the safety and efficacy of a new dosage form of Vardenafil, an orodispersible tablet (ODT), and compares it to the safety and efficacy of a placebo (inactive) tablet in the treatment of erectile…
- Trial name
- NCT00655629
- Testing
- Vardenafil ODT (STAXYN, BAY38-9456)
- Where
- 40 sites in United States, Australia and 2 more
- Volunteers
- 339 people
- Sponsor
- Bayer
Erectile Dysfunction
To Assess the Safety of Avanafil in Healthy and Hepatically Impaired Male Subjects.
The objective of this study is to assess the single dose pharmacokinetics of avanafil in subjects with hepatic impairment and in healthy control subjects.
- Trial name
- avanafil (NCT01054430)
- Testing
- avanafil
- Volunteers
- 27 people, healthy volunteers welcome
- Sponsor
- VIVUS LLC
Erectile Dysfunction
A Study of Semen Characteristics After 9 Months of Daily Tadalafil 20 mg
This is a multicenter, randomized, double-blind, placebo-controlled, fixed dose, parallel design study to evaluate effects on semen characteristics after 40 weeks of daily dosing with 20 mg tadalafil.
- Trial name
- NCT00382135
- Testing
- tadalafil
- Where
- United States
- Volunteers
- 282 people, healthy volunteers welcome
- Sponsor
- Eli Lilly and Company
Sexual Dysfunction, Male Erectile Dysfunction
Levitra (Vardenafil, BAY38-9456) Partner Satisfaction Study II
This trial is to provide additional important information on the impact of the treatment of the man its ED with vardenafil on partnership.
- Trial name
- NCT00377793
- Testing
- Levitra (Vardenafil, BAY38-9456)
- Where
- 47 sites in Belgium, France and 5 more
- Volunteers
- 352 people
- Sponsor
- Bayer
Healthy Male Volunteers
A Phase I Study to Investigate KH-001 in Healthy Males
This was a Phase I, first-in-human study of KH-001 besylate in healthy male participants, conducted to investigate the safety, tolerability and pharmacokinetics (PK) of the study drug.
- Trial name
- NCT07868237
- Testing
- KH-001 besylate
- Where
- United Kingdom
- Volunteers
- 82 people, healthy volunteers welcome
- Sponsor
- Kadence Bio
Endometriosis
Extension to Study on Efficacy and Safety of Linzagolix for the Treatment of Endometriosis-associated Pain
The primary objective of this extension study is to assess the maintenance of efficacy of linzagolix administered orally once daily for up to an additional 6 months (for up to 12 months of treatment in total) in women who have…
- Trial name
- EDELWEISS 5 (NCT04372121)
- Testing
- 75 mg linzagolix tablet, 200 mg linzagolix tablet, Add-back capsule (E2 1 mg / NETA 0.5 mg)
- Where
- 25 sites in United States, Canada and 1 more
- Volunteers
- 30 people
- Sponsor
- Kissei Pharmaceutical Co., Ltd.
Ejaculation
A Study of the Effectiveness and Safety of Dapoxetine in the Treatment of Men With Premature Ejaculation.
The primary purpose of the study is to demonstrate that dapoxetine can prolong intravaginal ejaculatory latency time (IELT) compared with placebo in men with premature ejaculation (PE).
- Trial name
- NCT00211107
- Testing
- Dapoxetine
- Volunteers
- 1,294 people
- Sponsor
- Alza Corporation, DE, USA
Erectile Dysfunction
To Investigate the Efficacy and Safety of Vardenafil in Men With Erectile Dysfunction.
To investigate the efficacy and safety of vardenafil in men with erectile dysfunction.
- Trial name
- NCT00661115
- Testing
- Levitra (Vardenafil, BAY38-9456)
- Where
- 6 sites in India
- Volunteers
- 173 people
- Sponsor
- Bayer
Erectile Dysfunction
Safety Study of Once-a-Day Dosing of Udenafil to Treat Erectile Dysfunction
Phase : Phase III Indication : Erectile Dysfunction Study Design : open-label, fixed dose, 6-month extension study (parent study : DA8159_EDD_III)
- Trial name
- NCT01901640
- Testing
- DA-8159 (Udenafil)
- Volunteers
- 302 people
- Sponsor
- Dong-A Pharmaceutical Co., Ltd.
Erectile Dysfunction
This Study is to Evaluate the Safety and Efficacy of Avanafil in the Treatment of Erectile Dysfunction.
The objective of this study is to evaluate the safety and efficacy of Avanafil in the treatment of erectile dysfunction with moderate to severe in subjects.
- Trial name
- SPEED (NCT01705197)
- Testing
- Avanafil 100 or 200mg
- Where
- South Korea
- Volunteers
- 195 people
- Sponsor
- JW Pharmaceutical
Premature Ejaculation
Clinical Trial to Evaluate the Efficacy and Safety of DA-8031 in Male Patients With Premature Ejaculation
This study is designed to evaluate the efficacy and safety of DA-8031 and to decide the optimal dose of DA-8031 in male patients with premature ejaculation after oral administration on-demand.
- Trial name
- NCT01798667
- Testing
- DA-8031
- Where
- South Korea
- Volunteers
- 220 people
- Sponsor
- Dong-A Pharmaceutical Co., Ltd.
Erectile Dysfunction
A Multicenter, Open Label, To Evaluate The Efficacy And Satisfaction Of Patrex® In Men With Erectile Dysfunction.
A multicenter open label study to assess the efficacy of sildenafil rapid dose titration to 100 mg in men with erectile dysfunction, based on the Erectile Function (EF) domain score of the International Index of Erectile Function…
- Trial name
- NCT00468650
- Testing
- sildenafil citrate
- Where
- 9 sites in Mexico
- Volunteers
- 117 people
- Sponsor
- Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Erectile Dysfunction
Pharmacokinetics Of Sildenafil Orally Disintegrating Tablet Formulation Given With Or Without Food.
This study will evaluate if an orally disintegrating tablet of sildenafil will have similar pharmacokinetic properties when given with food and without food.
- Trial name
- NCT01254396
- Testing
- Sildenafil
- Where
- Singapore
- Volunteers
- 12 people, healthy volunteers welcome
- Sponsor
- Pfizer's Upjohn has merged with Mylan to form Viatris Inc.